Accessibility navigation


Discovery of a human monoclonal antibody that cross-neutralizes venom phospholipase A2s from three different snake genera

Sørensen, C. V., Almeida, J. R. ORCID: https://orcid.org/0000-0002-4637-4468, Bohn, M.-F., Torre, E. R. d., Schoffelen, S., Voldborg, B. G., Ljungars, A., Vaiyapuri, S. ORCID: https://orcid.org/0000-0002-6006-6517 and Laustsen, A. H. (2023) Discovery of a human monoclonal antibody that cross-neutralizes venom phospholipase A2s from three different snake genera. Toxicon, 234. 107307. ISSN 0041-0101

[img]
Preview
Text (Open Access) - Published Version
· Available under License Creative Commons Attribution.
· Please see our End User Agreement before downloading.

1MB
[img] Text - Accepted Version
· Restricted to Repository staff only

469kB

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

To link to this item DOI: 10.1016/j.toxicon.2023.107307

Abstract/Summary

Despite the considerable global impact of snakebite envenoming, available treatments remain suboptimal. Here, we report the discovery of a broadly-neutralizing human monoclonal antibody, using a phage display-based cross-panning strategy, capable of reducing the cytotoxic effects (using a mouse myoblast cell line that may demonstrate the impact of venoms on skeletal muscle) of venom phospholipase A2s from three different snake genera from different continents. This highlights the potential of utilizing monoclonal antibodies to potentially compose more effective, safer, and globally accessible polyvalent antivenoms that hopefully can be widely applicable for snakebite envenomings.

Item Type:Article
Refereed:Yes
Divisions:Life Sciences > School of Chemistry, Food and Pharmacy > School of Pharmacy > Division of Pharmacology
ID Code:113507
Publisher:Elsevier

Downloads

Downloads per month over past year

University Staff: Request a correction | Centaur Editors: Update this record

Page navigation